Drug Topics Hospital Pharmacists' Report

June 1, 2012

Web Version  |  Manage Your Profile  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Statin therapy may benefit low-risk patients

Statin therapy is safe and effective for people at low risk of major vascular events and, therefore, current guidelines might need to be reconsidered, according to a study published online in The Lancet. » More

Continuing Education

Helping your patients control persistent asthma

Working in partnership with patients and physicians, pharmacists can help ensure optimal control of this common disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

CDC proposes expansion of hepatitis C guidelines

The Centers for Disease Control and Prevention is proposing an expansion of its current hepatitis C risk-based guidelines to include a simple, one-time blood test for anyone born from 1945 through 1965. » More

USPSTF recommends against hormone therapy

Women taking hormone replacement therapy face a complicated mix of possible benefits and risks, a new meta-analysis confirms. » More

Study: E-prescribing increase helps adherence, costs

The number of physicians and clinicians using e-prescribing increased by 67% in 2011 and they filled 75% more medication orders electronically, according to a new downloadable report by Surescripts, which operates a nationwide network connecting the computer systems of physicians and pharmacies. » More

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

Folic acid lowers child cancer risk

Long-acting contraceptive delivers results

Few girls finish 3 HPV shot series

FDA completes safety review of MS drug

Voices

Anticoagulation Update

JP at Large: Pharmacy’s own “1984”

View from the Zoo: Fox in the henhouse

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.